Spero-Smith Investment Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$291K Buy
1,743
+250
+17% +$42.3K 0.39% 42
2016
Q2
$227K Hold
1,493
0.28% 47
2016
Q1
$224K Sell
1,493
-100
-6% -$14.9K 0.28% 47
2015
Q4
$259K Sell
1,593
-31
-2% -$4.87K 0.33% 42
2015
Q3
$225K Hold
1,624
0.3% 40
2015
Q2
$249K Sell
1,624
-125
-7% -$20K 0.28% 42
2015
Q1
$280K Buy
1,749
+225
+15% +$35.4K 0.31% 42
2014
Q4
$242K Hold
1,524
0.28% 42
2014
Q3
$214K Buy
+1,524
New +$199K 0.25% 43

Other funds holding AMGN

Spero-Smith Investment Advisers's AMGN Position: Q3 2016 in Review

Spero-Smith Investment Advisers increased its Amgen (AMGN) stake by 17% in Q3 2016, buying an estimated $42.3K and bringing the position to 1,743 shares worth $291K. The position accounts for 0.39% of the portfolio, ranked #42.

Spero-Smith Investment Advisers first reported a position in AMGN in Q3 2014 and has held it in 9 quarters since. 1,518 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • Spero-Smith Investment Advisers held 1,743 shares of Amgen worth $291K as of Q3 2016.
  • Spero-Smith Investment Advisers bought 250 Amgen shares in Q3 2016, an estimated $42.3K.
  • Amgen made up 0.39% of Spero-Smith Investment Advisers's portfolio in Q3 2016, its #42 holding.
  • Spero-Smith Investment Advisers first reported a position in Amgen in Q3 2014 and has held it in 9 quarters since.
  • 1,518 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2016, filed 31 Oct 2016.